BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35182475)

  • 41. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
    Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
    Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics.
    Kishimoto T; Agarwal V; Kishi T; Leucht S; Kane JM; Correll CU
    Mol Psychiatry; 2013 Jan; 18(1):53-66. PubMed ID: 22124274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
    Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study.
    Gründer G; Heinze M; Cordes J; Mühlbauer B; Juckel G; Schulz C; Rüther E; Timm J;
    Lancet Psychiatry; 2016 Aug; 3(8):717-729. PubMed ID: 27265548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
    Emsley R; Chiliza B; Asmal L; du Plessis S; Phahladira L; van Niekerk E; van Rensburg SJ; Harvey BH
    Schizophr Res; 2014 Sep; 158(1-3):230-5. PubMed ID: 24996507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis.
    Uchida H; Suzuki T; Takeuchi H; Arenovich T; Mamo DC
    Schizophr Bull; 2011 Jul; 37(4):788-99. PubMed ID: 19946012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant NSAID use during antipsychotic treatment and risk of 2-year relapse - a population-based study of 16,253 incident patients with schizophrenia.
    Köhler O; Petersen L; Benros ME; Mors O; Gasse C
    Expert Opin Pharmacother; 2016 Jun; 17(8):1055-62. PubMed ID: 26988274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia.
    Takeuchi H; Siu C; Remington G; Fervaha G; Zipursky RB; Foussias G; Agid O
    Neuropsychopharmacology; 2019 May; 44(6):1036-1042. PubMed ID: 30514883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences.
    Taipale H; Puranen A; Mittendorfer-Rutz E; Tiihonen J; Tanskanen A; Cervenka S; Lähteenvuo M
    Nord J Psychiatry; 2021 Jul; 75(5):315-322. PubMed ID: 33331804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antipsychotics and antidepressants: an analysis of cost growth in Finland from 1999 to 2005.
    Koskinen H; Martikainen JE; Maljanen T
    Clin Ther; 2009 Jun; 31 Pt 1():1469-77. PubMed ID: 19698904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis.
    Rubio JM; Schoretsanitis G; John M; Tiihonen J; Taipale H; Guinart D; Malhotra AK; Correll CU; Kane JM
    Lancet Psychiatry; 2020 Sep; 7(9):749-761. PubMed ID: 32828165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antipsychotic Medications and Mortality in Children and Young Adults.
    Ray WA; Fuchs DC; Olfson M; Patrick SW; Stein CM; Murray KT; Daugherty J; Cooper WO
    JAMA Psychiatry; 2024 Mar; 81(3):260-269. PubMed ID: 38019523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New generation antipsychotics for first episode schizophrenia.
    Rummel C; Hamann J; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study.
    Denissoff A; Taipale H; Tiihonen J; Di Forti M; Mittendorfer-Rutz E; Tanskanen A; Mustonen A; Niemelä S
    Schizophr Bull; 2024 Mar; ():. PubMed ID: 38534050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.
    Puranen A; Koponen M; Tanskanen A; Tiihonen J; Taipale H
    Eur J Clin Pharmacol; 2020 May; 76(5):711-718. PubMed ID: 31940085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
    Wu CS; Wang SC; Yeh IJ; Liu SK
    J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine.
    Luykx JJ; Stam N; Tanskanen A; Tiihonen J; Taipale H
    Br J Psychiatry; 2020 Sep; 217(3):498-505. PubMed ID: 31910911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.